Updates in the Management of Myelofibrosis

16th International Congress on Myeloproliferative Neoplasms
Avatar

Allele Burden in MPN: Practical Considerations

By 16th International Congress on Myeloproliferative Neoplasms FEATURING Raajit Rampal
By 16th International Congress on Myeloproliferative Neoplasms FEATURING Raajit Rampal
235 views
November 26, 2024
Comments 0
Login to view comments. Click here to Login
18:07

Selection of JAK1/2 Inhibitors for Primary Myelofibrosis

16th International Congress on Myeloproliferative Neoplasms

A. Gerds

101 views
04:39

Selecting Frontline Therapy for Myelofibrosis

GRACE

A. Srisuwananukorn, S. Rajeeve, M. Salman Faisal

64 views
26:30

Predictors of Allogeneic Transplantation Outcome in Primary Myelofib…

16th International Congress on Myeloproliferative Neoplasms

K. van Besien

60 views
23:58

Clinical and Therapeutic Aspects of Chronic Inflammation in the MPNs

16th International Congress on Myeloproliferative Neoplasms

H. Hasselbalch

62 views
07:00

Approach to Selecting Treatment for Myelofibrosis in 2024

GRACE

A. Srisuwananukorn

64 views
20:15

Current and Future Treatment Landscape of Myelofibrosis

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

242 views
17:23

Management of MF After Ruxolitinib Failure

Vanderbilt University Medical Center (VUMC)

A. Kishtagari

227 views
29:17

Overview of Recent Updates in MPNs and MDS

UChicago Medicine

S. Kosuri

337 views
16:52

Updates on Myeloproliferative Neoplasms Including CML

Winship Cancer Institute - Emory University

A. Hunter

153 views
12:49

Emerging Therapies in MF & PV: Insights From Recent Clinical Trials

Yale Cancer Center

J. Bewersdorf

176 views
35:31

State of the Art and Next Questions: MPN

SOHO Highlights: State of the Art and Next Questions

J. Mascarenhas

272 views
11:39

2024 Updates in Myeloproliferative Neoplasms

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

E. Hexner

319 views
06:18

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

319 views
11:03

Current Treatment Landscape of JAK Inhibitors in MF

Moffitt Cancer Center

A. Kuykendall

243 views
07:51

Correlation of Bone Marrow Fibrosis Changes and Efficacy During Mome…

Mary Frances McMullin

220 views
05:06

Quality of Life in Myelofibrosis Patients Treated With Momelotinib

Mary Frances McMullin

222 views
10:08

Advances and Unmet Needs in MPN Treatment

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. Cilloni

82 views
24:48

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Indy Hematology Review

R. Rampal

375 views
12:18

QoL in Pts With MF: Highlighting the Need for New Agents

Jeanne Palmer

234 views
12:18

Management of MPNs for the Community Oncologist

Fred Hutchinson Cancer Center

H. Deeg

941 views
32:04

Experts Discuss the Latest Data in Myeloid Diseases

Moffitt Cancer Center

A. Kuykendall, R. Komrokji, O. Chan, D. Sallman

726 views